Can monoamine-based therapies be improved?DEMITRACK, Mark A.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 2, pp 14-18Article

Duloxetine in the treatment of major depressive disorder: A double-blind clinical trialGOLDSTEIN, David J; MALLINCKRODT, Craig; YILI LU et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 3, pp 225-231, issn 0160-6689Article

Chronic fatigue syndromeDEMITRACK, Mark A; LEVINE, Paul H.Journal of psychiatric research. 1997, Vol 31, Num 1, issn 0022-3956, 158 p.Conference Proceedings

Chronic fatigue syndrome criteria in patients with other forms of unexplained chronic fatigueCHESTER, A. C.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 45-50, issn 0022-3956Conference Paper

Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescentsROWE, K. S.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 133-147, issn 0022-3956Conference Paper

Precipitating factors for the chronic fatigue syndromeSALIT, I. E.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 59-65, issn 0022-3956Conference Paper

Epidemiologic advances in chronic fatigue syndromeLEVINE, P. H.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 7-18, issn 0022-3956Conference Paper

Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): Sleep factor changes during treatment in patients with pharmacoresistant major depressive disorderROSENQUIST, Peter B; KRYSTAL, Andrew; HEART, Karen L et al.Psychiatry research (Print). 2013, Vol 205, Num 1-2, pp 67-73, issn 0165-1781, 7 p.Article

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depressionDETKE, Michael J; YILI LU; GOLDSTEIN, David J et al.Journal of psychiatric research. 2002, Vol 36, Num 6, pp 383-390, issn 0022-3956Article

Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trialDETKE, Michael J; YILI LU; GOLDSTEIN, David J et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 4, pp 308-315, issn 0160-6689Article

Neuroendocrine correlates of chronic fatigue syndrome: A brief reviewDEMITRACK, M. A.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 69-82, issn 0022-3956Conference Paper

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression : A Multisite Randomized Controlled TrialO'REARDON, John P; SOLVASON, H. Brent; DEMITRACK, Mark A et al.Biological psychiatry (1969). 2007, Vol 62, Num 11, pp 1208-1216, issn 0006-3223, 9 p.Article

The natural history of concurrent sick building syndrome and chronic fatigue syndromeCHESTER, A. C; LEVINE, P. H.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 51-57, issn 0022-3956Conference Paper

Electron microscopic immunocytological profiles in chronic fatigue syndromeHOLMES, M. J; DIACK, D. S; EASINGWOOD, R. A et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 115-122, issn 0022-3956Conference Paper

Fatiguing illness among employees in three large state office buildings, California, 1993: Was there an outbreak?SHEFER, A; DOBBINS, J. G; FUKUDA, K et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 31-43, issn 0022-3956Conference Paper

Sudden vs gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measuresDELUCA, J; JOHNSON, S. K; ELLIS, S. P et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 83-90, issn 0022-3956Conference Paper

Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder : Clinical Response in an Open-Label Extension TrialAVERY, David H; ISENBERG, Keith E; SAMPSON, Shirlene M et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 3, pp 441-451, issn 0160-6689, 11 p.Article

Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder : A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction TreatmentJANICAK, Philip G; O'REARDON, John P; SAMPSON, Shirlene M et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 2, issn 0160-6689, 222-232 [11 p.]Article

Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetineGOLDSTEIN, David J; YILI LU; DETKE, Michael J et al.Journal of clinical psychopharmacology. 2004, Vol 24, Num 4, pp 389-399, issn 0271-0749, 11 p.Article

An epidemiologic study of fatigue with relevance for the chronic fatigue syndromeFUKUDA, K; DOBBINS, J. G; WILSON, L. J et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 19-29, issn 0022-3956Conference Paper

Gender differences in host defense mechanismsCANNON, J. G; PIERRE, B. A. S.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 99-113, issn 0022-3956Conference Paper

Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndromeBENNETT, A. L; MAYES, D. M; FAGIOLI, L. R et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 91-96, issn 0022-3956Conference Paper

Effects of duloxetine on painful physical symptoms associated with depressionGOLDSTEIN, David J; YILI LU; DETKE, Michael J et al.Psychosomatics (Washington, DC). 2004, Vol 45, Num 1, pp 17-28, issn 0033-3182, 12 p.Article

Abnormalities in response to vasopressin infusion in chronic fatigue syndromeALTEMUS, Margaret; DALE, Janet K; MICHELSON, David et al.Psychoneuroendocrinology. 2001, Vol 26, Num 2, pp 175-188, issn 0306-4530Article

Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndromeGUPTA, S; AGGARWAL, S; SEE, D et al.Journal of psychiatric research. 1997, Vol 31, Num 1, pp 149-156, issn 0022-3956Conference Paper